BeOne Medicines (ONC) Assets Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.43% |
| Dec 31, 2025 | 38.30% |
| Sep 30, 2025 | 30.90% |
| Jun 30, 2025 | 10.26% |
| Mar 31, 2025 | 3.07% |
| Dec 31, 2024 | 1.99% |
| Sep 30, 2024 | 5.54% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | -4.85% |
| Dec 31, 2023 | 5.91% |
| Sep 30, 2023 | -17.86% |
| Jun 30, 2023 | -22.36% |
| Mar 31, 2023 | -25.74% |
| Dec 31, 2022 | -35.78% |
| Sep 30, 2022 | 27.23% |
| Jun 30, 2022 | 33.56% |
| Mar 31, 2022 | 37.80% |
| Dec 31, 2021 | 52.40% |
| Sep 30, 2021 | -5.03% |
| Jun 30, 2021 | 41.52% |
| Mar 31, 2021 | 43.12% |
| Dec 31, 2020 | 247.38% |
| Sep 30, 2020 | 195.92% |
| Jun 30, 2020 | 81.52% |
| Mar 31, 2020 | 87.24% |
| Dec 31, 2019 | -28.33% |
| Sep 30, 2019 | -21.90% |
| Jun 30, 2019 | 30.02% |
| Mar 31, 2019 | 27.11% |
| Dec 31, 2018 | 114.98% |
| Sep 30, 2018 | 129.60% |
| Jun 30, 2018 | 248.93% |
| Mar 31, 2018 | 353.62% |
| Dec 31, 2017 | 157.87% |
| Sep 30, 2017 | 345.60% |
| Jun 30, 2017 | 88.66% |
| Mar 31, 2017 | 42.04% |
| Dec 31, 2016 | 247.55% |